News & Analysis on Pharmaceutical Technology & Manufacturing
MHRA: Ian Hudson
By Maggie Lynch
- Last updated on
Ian Hudson, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA), will be leaving the agency in September 2019.
Hudson stated, “My reasons for stepping down are both personal and professional. I had always intended to reduce my total work commitment to enable me to pursue other things and perhaps have more of a portfolio career by the time I reached 60, which has now happened.”
His retirement will not occur until next year in order to ensure that a proper successor is in place and a handover can be arranged. Until then, Hudson said he will continue to focus on leading the agency.
Hudson has spent 17 years with the agency. He served as MHRA’s licensing director until 2013 and in that role he was responsible for the majority of medicines licensing activity. For the past five years, he has lead the company as its chief executive.
Before entering the pharmaceutical industry, Hudson worked as a pediatrician, before entering clinical research and development industry in 1989.